LewisBarrySilvermanMD

Pediatric Hematology & Oncology • New York, NY

Director of the Hope and Heroes Division of Pediatric Hematology, Oncology and Stem Cell Transplantation at NewYork-Presbyterian Morgan Stanley Children’s Hospital and Columbia University Vagelos College of Physicians and Surgeons. Hettinger Chair in the Department of Pediatrics at Columbia. Associate Director of Pediatric Cancers at the Herbert Irving Comprehensive Cancer Center.

Join to view full profile

Dr. Silverman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Silverman's full profile

Already have an account?

Office
161 Fort Washington Ave
Fl 7
New York, NY 10032
Phone+1 212-305-9770

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1994 - 1997
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1991 - 1994
Harvard Medical SchoolClass of 1991

Certifications & Licensure

ME State Medical License 2022 - 2026
NY State Medical License 2024 - 2026
RI State Medical License 2022 - 2026
CT State Medical License 2022 - 2025
MA State Medical License 1994 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Treatment of Acute Lymphoblastic Leukemia in Children Start of enrollment: 2000 Sep 01
Completed
Phase 3
Treatment of Acute Lymphoblastic Leukemia in Children Start of enrollment: 2005 Apr 01
Completed
Phase 3
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia Start of enrollment: 2006 Jan 01
Recruiting
Not Applicable
Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL Start of enrollment: 2011 Nov 01
Completed
Phase 1
SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Start of enrollment: 2012 Jun 01
Active, not recruiting
Phase 2
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Start of enrollment: 2017 Aug 08
Recruiting
Phase 3
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents Start of enrollment: 2017 Mar 03
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Feasibility of Utilizing a Brief Neurocognitive Battery in 3-Year-Old Patients During Treatment for Acute Lymphoblastic Leukemia.
Sameera Ramjan, Peter D Cole, Melanie Blair-Thies, Lewis B Silverman, Amy Fredrickson
Pediatric Blood & Cancer. 2024-12-09
Genome-wide study identifies novel genes associated with bone toxicities in children with acute lymphoblastic leukaemia.
Qianqian Zhu, Ram Nambiar, Emily Schultz, Xinyu Gao, Shuyi Liang
British Journal of Haematology. 2024-11-01
Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort.
Rahela Aziz-Bose, Colin Cernik, Puja J Umaretiya, Lenka Ilcisin, Colleen A Kelly
Pediatric Blood & Cancer. 2024-11-01

Abstracts/Posters

Single Cell RNA-Seq Reveals Deranged Developmental Hierarchy with Coexisting Oncogenic States and Immune Evasion Programs in ETP T-ALL
Lewis B. Silverman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Genetic Ancestry and Skeletal Toxicities Among Childhood Acute Lymphoblastic Leukemia Patients in the DFCI 05-001 Cohort
Lewis B. Silverman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

New Data and Paradigms in ALL: Insights and Applications
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Enhancing Cancer Cure Quality for KidsSeptember 6th, 2024
Dr. Lewis Silverman to Lead Pediatric Hematology, Oncology and Stem Cell Transplantation at NewYork-Presbyterian Morgan Stanley Children’s Hospital and Columbia UniversityAugust 29th, 2024

Grant Support

Treatment Of Childhood And Adult AllNational Cancer Institute2006–2010
Pharmacogenetics Of Asparaginase-Induced PancreatitisEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2007

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member